1. Home
  2. COCP vs FRSX Comparison

COCP vs FRSX Comparison

Compare COCP & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • FRSX
  • Stock Information
  • Founded
  • COCP 2006
  • FRSX N/A
  • Country
  • COCP United States
  • FRSX Israel
  • Employees
  • COCP N/A
  • FRSX N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • COCP Health Care
  • FRSX Technology
  • Exchange
  • COCP Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • COCP 15.4M
  • FRSX 12.6M
  • IPO Year
  • COCP N/A
  • FRSX 2017
  • Fundamental
  • Price
  • COCP $1.45
  • FRSX $0.60
  • Analyst Decision
  • COCP Strong Buy
  • FRSX
  • Analyst Count
  • COCP 1
  • FRSX 0
  • Target Price
  • COCP $7.00
  • FRSX N/A
  • AVG Volume (30 Days)
  • COCP 15.8K
  • FRSX 97.5K
  • Earning Date
  • COCP 05-27-2025
  • FRSX 05-27-2025
  • Dividend Yield
  • COCP N/A
  • FRSX N/A
  • EPS Growth
  • COCP N/A
  • FRSX N/A
  • EPS
  • COCP N/A
  • FRSX N/A
  • Revenue
  • COCP N/A
  • FRSX $436,000.00
  • Revenue This Year
  • COCP N/A
  • FRSX N/A
  • Revenue Next Year
  • COCP N/A
  • FRSX N/A
  • P/E Ratio
  • COCP N/A
  • FRSX N/A
  • Revenue Growth
  • COCP N/A
  • FRSX N/A
  • 52 Week Low
  • COCP $1.12
  • FRSX $0.55
  • 52 Week High
  • COCP $3.26
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • COCP 52.12
  • FRSX 41.57
  • Support Level
  • COCP $1.46
  • FRSX $0.52
  • Resistance Level
  • COCP $1.79
  • FRSX $0.74
  • Average True Range (ATR)
  • COCP 0.16
  • FRSX 0.06
  • MACD
  • COCP 0.00
  • FRSX -0.01
  • Stochastic Oscillator
  • COCP 40.00
  • FRSX 37.57

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: